Effects of janus-kinase inhibitor therapy on lipid parameters in patients with IBD

被引：0
|
作者：
Prabhu, A. [1 ]
Al Dehailan, R. [1 ]
Azzu, H. [1 ]
Sanford, J. [1 ]
Cripps, S. [1 ]
Scaria, L. [1 ]
Walsh, A. [1 ]
机构：
[1] Oxford Univ Hosp NHS Fdn Trust, Translat Gastroenterol Unit, Oxford, England
来源：
JOURNAL OF CROHNS & COLITIS | 2025年 / 19卷
关键词：
RHEUMATOID-ARTHRITIS;
D O I：
10.1093/ecco-jcc/jjae190.1335
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P1161
引用
收藏
页码：i2123 / i2123
页数：1
相关论文
共 50 条
  • [41] Evaluating dermatologists' knowledge of and attitudes toward Janus kinase inhibitor therapy for the treatment of alopecia areata
    Nohria, Ambika
    Desai, Deesha
    Lee, Alison
    Karagounis, Theodora
    Shapiro, Jerry
    Garshick, Michael
    Lo Sicco, Kristen I.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2024, 91 (05) : 976 - 978
  • [42] Biomimetic polydopamine loaded with janus kinase inhibitor for synergistic vitiligo therapy via hydrogel microneedles
    Li, Chunying
    Wang, Wenwen
    Shao, Junyi
    Zhou, Sen
    Ji, Xiaolin
    Xi, Youxia
    Xu, Qiuyang
    Huang, Yuhan
    Wang, Jingle
    Wan, Yilin
    Li, Zhiming
    JOURNAL OF NANOBIOTECHNOLOGY, 2025, 23 (01)
  • [43] Janus Kinase Inhibitor Therapy and Risk of Age-Related Macular Degeneration in Autoimmune Disease
    Hallak, Joelle A.
    Abbasi, Ali
    Goldberg, Roger A.
    Modi, Yasha
    Zhao, Changgeng
    Jing, Yonghua
    Chen, Naijun
    Mercer, Daniel
    Sahu, Soumya
    Alobaidi, Ali
    Lopez, Francisco J.
    Luhrs, Keith
    Waring, Jeffrey F.
    den Hollander, Anneke I.
    Smaoui, Nizar
    JAMA OPHTHALMOLOGY, 2024, 142 (08) : 750 - 758
  • [44] Effects of adjuvant aromatase inhibitor therapy on lipid profiles
    Monnier, Alain
    EXPERT REVIEW OF ANTICANCER THERAPY, 2006, 6 (11) : 1653 - 1662
  • [45] Management of cutaneous lupus erythematosus with Janus kinase inhibitor therapy: An evidence-based review
    Abduelmula, Abrahim
    Sood, Siddhartha
    Mufti, Asfandyar
    Hinek, Anna
    Yeung, Jensen
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (01) : 130 - 131
  • [46] Improvement in Ulcerative Necrobiosis Lipoidica After Janus Kinase-Inhibitor Therapy for Polycythemia Vera
    Lee, Jonathan J.
    English, Joseph C., III
    JAMA DERMATOLOGY, 2018, 154 (06) : 733 - 734
  • [47] Resolution of ocular and mediastinal sarcoidosis after Janus kinase inhibitor therapy for concomitant rheumatoid arthritis
    Sejournet, L.
    Kodjikian, L.
    Grange, L.
    Grumet, P.
    Jamilloux, Y.
    Seve, P.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2021, 39 (01) : 225 - 226
  • [48] Identification and validation of the association of Janus kinase 2 mutations with the response to immune checkpoint inhibitor therapy
    Peipei Chen
    Junyu Long
    Jiayang Zhang
    Fucun Xie
    Wei Wu
    Zhuang Tian
    Shuyang Zhang
    Kang Yu
    Inflammation Research, 2024, 73 : 263 - 276
  • [49] Effects of HIV protease inhibitor therapy on lipid metabolism
    Hui, DY
    PROGRESS IN LIPID RESEARCH, 2003, 42 (02) : 81 - 92
  • [50] The Effect of Fedratinib, A Selective Inhibitor of Janus Kinase 2, on Weight and Metabolic Parameters in Patients with Intermediate- or High-risk Myelofibrosis
    Tremblay, Douglas
    Cavalli, Lara
    Sy, Oumar
    Rose, Shelonitda
    Mascarenhas, John
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 (07): : E463 - E466
12345